$7.40
1.93% today
NYSE, Feb 05, 04:20 pm CET
ISIN
CA0717341071
Symbol
BHC
Sector
Industry

Bausch Health Companies Inc. Stock price

$7.26
-0.54 6.92% 1M
+2.03 38.81% 6M
-0.80 9.93% YTD
-0.51 6.56% 1Y
-17.26 70.39% 3Y
-21.56 74.81% 5Y
-153.61 95.49% 10Y
NYSE, Closing price Tue, Feb 04 2025
-0.02 0.27%
ISIN
CA0717341071
Symbol
BHC
Sector
Industry

Key metrics

Market capitalization $2.67b
Enterprise Value $24.36b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 23.47
EV/Sales (TTM) EV/Sales 2.57
P/S ratio (TTM) P/S ratio 0.28
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 10.91%
Revenue (TTM) Revenue $9.47b
EBIT (operating result TTM) EBIT $1.77b
Free Cash Flow (TTM) Free Cash Flow $1.04b
Cash position $750.00m
EPS (TTM) EPS $-0.49
P/E forward negative
P/S forward 0.28
EV/Sales forward 2.54
Short interest 2.43%
Show more

Is Bausch Health Companies Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Bausch Health Companies Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Bausch Health Companies Inc. forecast:

1x Buy
17%
4x Hold
67%
1x Sell
17%

Analyst Opinions

6 Analysts have issued a Bausch Health Companies Inc. forecast:

Buy
17%
Hold
67%
Sell
17%

Financial data from Bausch Health Companies Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
9,474 9,474
11% 11%
100%
- Direct Costs 3,860 3,860
7% 7%
41%
5,614 5,614
14% 14%
59%
- Selling and Administrative Expenses 1,953 1,953
29% 29%
21%
- Research and Development Expense 605 605
2% 2%
6%
3,056 3,056
8% 8%
32%
- Depreciation and Amortization 1,289 1,289
0% 0%
14%
EBIT (Operating Income) EBIT 1,767 1,767
16% 16%
19%
Net Profit -178 -178
82% 82%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about Bausch Health Companies Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bausch Health Companies Inc. Stock News

Neutral
Accesswire
13 days ago
LAVAL, QC / ACCESS Newswire / January 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release fourth quarter and full year 2024 financial results after market close on Wednesday, February 19, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m.
Neutral
Business Wire
14 days ago
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2024 financial results on Wednesday, February 19, 2025. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update....
Neutral
Accesswire
19 days ago
LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today acknowledged that the Centers for Medicare and Medicaid Services (CMS) has selected XIFAXAN® (rifaximin) 550 mg tablets as one of the medicines for the second round of negotiation as part of the Inflation Reduction Act with an ini...
More Bausch Health Companies Inc. News

Company Profile

Manufactures and markets pharmaceutical products

Head office Canada
CEO Thomas Appio
Employees 20,270
Founded 1994
Website www.bauschhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today